Published in
Elsevier, Clinical Breast Cancer, 1(18), p. 88-94
DOI: 10.1016/j.clbc.2017.10.013
Links
Tools
Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group
Journal article published in 2018 by
Emmanouil Saloustros 
,
Michail Nikolaou ,
Konstantinos Kalbakis,
Aris Polyzos,
Charalampos Christofillakis,
Nikolaos Kentepozidis ,
Nikolaos Pistamaltzian,
Charalampos Kourousis,
Lampros Vamvakas,
Vasilios Georgoulias,
Dimitris Mavroudis
,
Michail Nikolaou ,
Konstantinos Kalbakis,
Aris Polyzos,
Charalampos Christofillakis,
Nikolaos Kentepozidis ,
Nikolaos Pistamaltzian,
Charalampos Kourousis,
Lampros Vamvakas,
Vasilios Georgoulias,
Dimitris Mavroudis
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 